Skip to main content
Clinical Trials/IRCT20140212016557N7
IRCT20140212016557N7
Recruiting
Phase 3

Comparison of the effect of intralesional injection of methotrexate and triamcinolone in the treatment of nail psoriasis

Shiraz University of Medical Sciences0 sites78 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
ail psoriasis.
Sponsor
Shiraz University of Medical Sciences
Enrollment
78
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients between 16 and 70 years of age
  • Clinically\- or pathologically confirmed nail psoriasis that have involvement of one or more fingernails with psoriasis

Exclusion Criteria

  • Patients with involvement of 5 or more nails
  • Patients who received systemic or topical medication (for nail) in the last 3 months
  • Patients with skin involvement of more than 20% that need systemic treatment
  • Patients with nail fungal infection
  • History of hypersensitivity reactions to lidocaine, triamcinolone, or methotrexate
  • Diabetic patients
  • Immunocompromised patients
  • Patients with active peptic ulcer, gastritis, ascitis, and pleural effusion
  • Concomitant use of hepatotoxic drugs, or drugs that interfere with methotrexate metabolism
  • Concomitant radiotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials